What is the recommended management for Tarlov cysts, including indications for observation, conservative therapy, and surgical intervention?

Management of Tarlov Cysts

For symptomatic Tarlov cysts, CT-guided aspiration with fibrin glue injection should be the first-line interventional treatment, as it provides symptom improvement in 61-66% of patients with minimal complications and no CSF leakage risk, while asymptomatic cysts require only reassurance without long-term imaging surveillance.

Initial Assessment and Observation

Most Tarlov cysts (>80%) are asymptomatic incidental findings that remain stable over time and require conservative management with patient counseling and reassurance 1. For asymptomatic cysts, even serial imaging is of uncertain value since most demonstrate stable size and characteristics 1. If you discover an asymptomatic cyst, provide reassurance and avoid unnecessary follow-up imaging unless concerning features develop.

For patients with nonspecific symptoms like headache or fatigue, obtain 2 sequential scans separated by approximately 1 year to demonstrate stability, then discontinue imaging if stable and tumor markers are normal 1.

Identifying Truly Symptomatic Cysts

The critical clinical challenge is determining which cysts are actually causing symptoms. Look for this specific symptom constellation that indicates sacral nerve root involvement:

• Sitting intolerance (highly discriminating feature) 2
• Sacral or perineal sensory changes (highly discriminating feature) 2
• Back pain, coccyx pain, or low radicular pain 3
• Bladder/bowel dysfunction 4, 3
• Sexual dysfunction, including persistent genital arousal disorder 5, 6
• Leg weakness 3

Important caveat: Cyst size alone does not predict clinical relevance 2. Instead, look for radiological markers of nerve compression: dorsal root ganglion displacement and sacral foraminal remodeling 2.

Diagnostic Algorithm Before Intervention

Before proceeding with any intervention, you must:

1. Exclude differential diagnoses: gynecological, urological, and colorectal causes of pelvic/perineal symptoms 2
2. Correlate symptoms with anatomical level of the cyst 2
3. Consider neurogenital testing and assessment for pelvic or end-organ triggers 5
4. Perform targeted diagnostic injection with anesthetic and steroid to confirm the cyst is the symptomatic driver 5

This diagnostic injection serves dual purposes: confirming symptom etiology and identifying patients who achieve temporary improvement as potential surgical candidates 4.

Treatment Hierarchy

First-Line Interventional Treatment: CT-Guided Aspiration with Fibrin Glue

C-arm fluoroscopy guided percutaneous fibrin gel injection is the superior first-line intervention 7. The evidence strongly favors this approach:

• 61% complete resolution and 39% substantial resolution of symptoms 7
• No CSF leakage complications 7
• No recurrence in the reported series 7
• Can serve as both diagnostic and therapeutic tool 4

In the largest comparative study, this approach outperformed both conservative management (which showed 75% symptom aggravation) and had fewer complications than microsurgery 7.

Second-Line Treatment: Microsurgical Intervention

Reserve microsurgical cyst fenestration and imbrication for:

• Patients who achieved temporary improvement with aspiration/fibrin injection but experienced recurrence 4
• Patients with documented neurological deterioration 8
• Selected cases with persistent symptoms despite percutaneous treatment

Surgical outcomes: 50% complete resolution and 50% substantial resolution, but with significant complications including 21% CSF leakage and 21% recurrent symptoms 7. Another series showed 78.3% of patients had undergone prior interventions without sustained improvement before surgery 9.

Critical prognostic factors for poor surgical outcomes 9:

• Advanced age (p = 0.045)
• Multiple perineural cysts on imaging (p = 0.02)
• Longer duration of preoperative symptoms (p = 0.03)

Therefore, earlier intervention is preferable if surgery becomes necessary, as prolonged symptom duration predicts worse outcomes.

Special Consideration: PGAD/GPD

For patients with persistent genital arousal disorder or genito-pelvic dysesthesia, the diagnostic algorithm must include neurogenital testing and sacral MRI 5. When Tarlov cysts are identified as the symptomatic driver through targeted diagnostic injection, surgical excision and imbrication achieved 73.7% improvement rates with no CSF leaks or recurrences 5. This represents a specific indication where surgical intervention may be first-line after diagnostic confirmation.

What NOT to Do

• Do not perform surgery on asymptomatic cysts - they remain stable in >80% of cases 1
• Do not rely on cyst size alone to determine clinical significance 2
• Do not proceed to surgery without first attempting percutaneous fibrin injection unless there is documented neurological deterioration 7
• Do not operate on patients with prolonged symptom duration (>47 months) without careful counseling about reduced success rates 9
• Do not expect pain to improve as reliably as neurological deficits - neurological symptoms respond better to surgery than pain 3

Common Pitfalls

The most significant pitfall is attributing nonspecific low back pain to incidental Tarlov cysts. Many patients undergo unnecessary interventions when their symptoms overlap with other common causes of low-back pain 9. The diagnostic injection is your best tool to avoid this error.

Another pitfall: failing to recognize pelvic extension of sacral Tarlov cysts, which can mimic adnexal masses on ultrasound 8. When cystic pelvic lesions coexist with radicular pain or sitting intolerance, obtain MRI before considering gynecologic surgery 8.